Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
International Journal of Biological Sciences|February 16, 2026
Human umbilical cord mesenchymal stem cell delivery of mitochondria to melanocytes enhances skin repigmentation efficacy in autologous epidermal cell suspension transplantation through the TNFAIP2-TNT systemXiaodong Jin, Shishi Xiong, Bo Wang, et al.
Frontiers in Microbiology|December 31, 2020
Gut Microbial Dysbiosis and Plasma Metabolic Profile in Individuals With VitiligoQingrong Ni, Zhubiao Ye, Yinghan Wang, et al.
The Journal of Investigative Dermatology|November 15, 2021
HSF1-Dependent Autophagy Activation Contributes to the Survival of Melanocytes Under Oxidative Stress in VitiligoTingting Cui, Yinghan Wang, Pu Song, et al.
Emerging Microbes & Infections|October 13, 2020
Balamuthia mandrillaris infection in China: a retrospective report of 28 casesLei Wang, Wenjing Cheng, Bing Li, et al.
The Journal of Allergy and Clinical Immunology|November 10, 2016
Oxidative stress drives CD8+ T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytesShuli Li, Guannan Zhu, Yuqi Yang, et al.
Clinical Science (London, England : 1979)|May 14, 2020
Homocysteine induces melanocytes apoptosis via PERK-eIF2α-CHOP pathway in vitiligoJiaxi Chen, Tongtian Zhuang, Jianru Chen, et al.
Free Radical Biology & Medicine|May 13, 2019
Oxidative stress-induced IL-15 trans-presentation in keratinocytes contributes to CD8+ T cells activation via JAK-STAT pathway in vitiligoXuguang Chen, Weinan Guo, Yuqian Chang, et al.
The Journal of Investigative Dermatology|March 28, 2018
Downregulated TRPV1 Expression Contributes to Melanoma Growth via the Calcineurin-ATF3-p53 PathwayYuqi Yang, Weinan Guo, Jingjing Ma, et al.
Life Sciences|January 14, 2026
Cabozantinib induces NLRP3-CASP1-GSDMD-dependent pyroptosis in hepatocellular carcinomaLi Lin, Chiun Hsu, Chia-Lang Hsu, et al.
Acta Pharmacologica Sinica|June 6, 2025
Modeling exposure-driven adverse events of EGFR TKIs in the treatment of patients with non-small cell lung cancerLing Yong, Yan'e Liu, Wei-Zhe Jian, et al.
Pageof 8